Among the companies with shares expected to actively trade in
Monday's session is Actavis Inc. (ACT).
Drug maker Valeant Pharmaceuticals International Inc. (VRX,
VRX.T) is in talks to acquire rival Actavis for more than $13
billion, The Wall Street Journal reported, citing people familiar
with the matter, in what would rank as one of the biggest
health-care deals this year. Actavis shares rose 2.5% to $103.50
after hours.
Watchlist:
Hedge fund Aurelius Capital Management LP has filed a lawsuit
against Clearwire Corp. (CLWR) and Sprint Nextel Corp. (S),
claiming the terms of the companies' proposed $2.2 billion merger
are unfair to Clearwire's minority shareholders.
J.C. Penney Co. (JCP) has a commitment for a $1.75 billion loan
being arranged by Goldman Sachs Group Inc. (GS), people familiar
with the matter said Friday.
Write to Nathalie Tadena at nathalie.tadena@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires